187 related articles for article (PubMed ID: 24566669)
21. Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry to Detect Diagnostic Glycopeptide Markers of Congenital Disorders of Glycosylation.
Wada Y
Mass Spectrom (Tokyo); 2020; 9(1):A0084. PubMed ID: 32547898
[TBL] [Abstract][Full Text] [Related]
22. Single-center experience of N-linked Congenital Disorders of Glycosylation with a Summary of Molecularly Characterized Cases in Arabs.
Bastaki F; Bizzari S; Hamici S; Nair P; Mohamed M; Saif F; Malik EM; Al-Ali MT; Hamzeh AR
Ann Hum Genet; 2018 Jan; 82(1):35-47. PubMed ID: 28940310
[TBL] [Abstract][Full Text] [Related]
23. Congenital Disorders of Glycosylation in Portugal-Two Decades of Experience.
Quelhas D; Martins E; Azevedo L; Bandeira A; Diogo L; Garcia P; Sequeira S; Ferreira AC; Teles EL; Rodrigues E; Fortuna AM; Mendonça C; Fernandes HC; Medeira A; Gaspar A; Janeiro P; Oliveira A; Laranjeira F; Ribeiro I; Souche E; Race V; Keldermans L; Matthijs G; Jaeken J
J Pediatr; 2021 Apr; 231():148-156. PubMed ID: 33340551
[TBL] [Abstract][Full Text] [Related]
24. Establishing SON in 21q22.11 as a cause a new syndromic form of intellectual disability: Possible contribution to Braddock-Carey syndrome phenotype.
Takenouchi T; Miura K; Uehara T; Mizuno S; Kosaki K
Am J Med Genet A; 2016 Oct; 170(10):2587-90. PubMed ID: 27256762
[TBL] [Abstract][Full Text] [Related]
25. Application of whole-exome sequencing to unravel the molecular basis of undiagnosed syndromic congenital neutropenia with intellectual disability.
Gauthier-Vasserot A; Thauvin-Robinet C; Bruel AL; Duffourd Y; St-Onge J; Jouan T; Rivière JB; Heron D; Donadieu J; Bellanné-Chantelot C; Briandet C; Huet F; Kuentz P; Lehalle D; Duplomb-Jego L; Gautier E; Maystadt I; Pinson L; Amram D; El Chehadeh S; Melki J; Julia S; Faivre L; Thevenon J
Am J Med Genet A; 2017 Jan; 173(1):62-71. PubMed ID: 27615324
[TBL] [Abstract][Full Text] [Related]
26. Translational balancing questioned: Unaltered glycosylation during disulfiram treatment in mannosyl-oligosaccharide alpha-1,2-mannnosidase-congenital disorders of glycosylation (MAN1B1-CDG).
Kemme L; Grüneberg M; Reunert J; Rust S; Park J; Westermann C; Wada Y; Schwartz O; Marquardt T
JIMD Rep; 2021 Jul; 60(1):42-55. PubMed ID: 34258140
[TBL] [Abstract][Full Text] [Related]
27. ALG13 X-linked intellectual disability: New variants, glycosylation analysis, and expanded phenotypes.
Alsharhan H; He M; Edmondson AC; Daniel EJP; Chen J; Donald T; Bakhtiari S; Amor DJ; Jones EA; Vassallo G; Vincent M; Cogné B; Deb W; Werners AH; Jin SC; Bilguvar K; Christodoulou J; Webster RI; Yearwood KR; Ng BG; Freeze HH; Kruer MC; Li D; Raymond KM; Bhoj EJ; Sobering AK
J Inherit Metab Dis; 2021 Jul; 44(4):1001-1012. PubMed ID: 33734437
[TBL] [Abstract][Full Text] [Related]
28. Conserved oligomeric Golgi complex subunit 1 deficiency reveals a previously uncharacterized congenital disorder of glycosylation type II.
Foulquier F; Vasile E; Schollen E; Callewaert N; Raemaekers T; Quelhas D; Jaeken J; Mills P; Winchester B; Krieger M; Annaert W; Matthijs G
Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3764-9. PubMed ID: 16537452
[TBL] [Abstract][Full Text] [Related]
29. A biallelic loss-of-function variant in TMEM147 causes profound intellectual disability and spasticity.
Ghorashi T; Darvish H; Bakhtiari S; Tafakhori A; Kruer MC; Mozdarani H
Neurogenetics; 2023 Oct; 24(4):311-316. PubMed ID: 37668766
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic exome sequencing in persons with severe intellectual disability.
de Ligt J; Willemsen MH; van Bon BW; Kleefstra T; Yntema HG; Kroes T; Vulto-van Silfhout AT; Koolen DA; de Vries P; Gilissen C; del Rosario M; Hoischen A; Scheffer H; de Vries BB; Brunner HG; Veltman JA; Vissers LE
N Engl J Med; 2012 Nov; 367(20):1921-9. PubMed ID: 23033978
[TBL] [Abstract][Full Text] [Related]
31. Exome sequencing unravels unexpected differential diagnoses in individuals with the tentative diagnosis of Coffin-Siris and Nicolaides-Baraitser syndromes.
Bramswig NC; Lüdecke HJ; Alanay Y; Albrecht B; Barthelmie A; Boduroglu K; Braunholz D; Caliebe A; Chrzanowska KH; Czeschik JC; Endele S; Graf E; Guillén-Navarro E; Kiper PÖ; López-González V; Parenti I; Pozojevic J; Utine GE; Wieland T; Kaiser FJ; Wollnik B; Strom TM; Wieczorek D
Hum Genet; 2015 Jun; 134(6):553-68. PubMed ID: 25724810
[TBL] [Abstract][Full Text] [Related]
32. A novel syndrome of hypohidrosis and intellectual disability is linked to COG6 deficiency.
Shaheen R; Ansari S; Alshammari MJ; Alkhalidi H; Alrukban H; Eyaid W; Alkuraya FS
J Med Genet; 2013 Jul; 50(7):431-6. PubMed ID: 23606727
[TBL] [Abstract][Full Text] [Related]
33. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features.
Battaglia A; Doccini V; Bernardini L; Novelli A; Loddo S; Capalbo A; Filippi T; Carey JC
Eur J Paediatr Neurol; 2013 Nov; 17(6):589-99. PubMed ID: 23711909
[TBL] [Abstract][Full Text] [Related]
34. Intellectual disability and bleeding diathesis due to deficient CMP--sialic acid transport.
Mohamed M; Ashikov A; Guillard M; Robben JH; Schmidt S; van den Heuvel B; de Brouwer AP; Gerardy-Schahn R; Deen PM; Wevers RA; Lefeber DJ; Morava E
Neurology; 2013 Aug; 81(7):681-7. PubMed ID: 23873973
[TBL] [Abstract][Full Text] [Related]
35. Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie.
Imbach T; Schenk B; Schollen E; Burda P; Stutz A; Grunewald S; Bailie NM; King MD; Jaeken J; Matthijs G; Berger EG; Aebi M; Hennet T
J Clin Invest; 2000 Jan; 105(2):233-9. PubMed ID: 10642602
[TBL] [Abstract][Full Text] [Related]
36. Active site variants in STT3A cause a dominant type I congenital disorder of glycosylation with neuromusculoskeletal findings.
Wilson MP; Garanto A; Pinto E Vairo F; Ng BG; Ranatunga WK; Ventouratou M; Baerenfaenger M; Huijben K; Thiel C; Ashikov A; Keldermans L; Souche E; Vuillaumier-Barrot S; Dupré T; Michelakakis H; Fiumara A; Pitt J; White SM; Lim SC; Gallacher L; Peters H; Rymen D; Witters P; Ribes A; Morales-Romero B; Rodríguez-Palmero A; Ballhausen D; de Lonlay P; Barone R; Janssen MCH; Jaeken J; Freeze HH; Matthijs G; Morava E; Lefeber DJ
Am J Hum Genet; 2021 Nov; 108(11):2130-2144. PubMed ID: 34653363
[TBL] [Abstract][Full Text] [Related]
37. A recessive syndrome of intellectual disability, moderate overgrowth, and renal dysplasia predisposing to Wilms tumor is caused by a mutation in FIBP gene.
Akawi N; Ben-Salem S; Lahti L; Partanen J; Ali BR; Al-Gazali L
Am J Med Genet A; 2016 Aug; 170(8):2111-8. PubMed ID: 27183861
[TBL] [Abstract][Full Text] [Related]
38. Eight further individuals with intellectual disability and epilepsy carrying bi-allelic CNTNAP2 aberrations allow delineation of the mutational and phenotypic spectrum.
Smogavec M; Cleall A; Hoyer J; Lederer D; Nassogne MC; Palmer EE; Deprez M; Benoit V; Maystadt I; Noakes C; Leal A; Shaw M; Gecz J; Raymond L; Reis A; Shears D; Brockmann K; Zweier C
J Med Genet; 2016 Dec; 53(12):820-827. PubMed ID: 27439707
[TBL] [Abstract][Full Text] [Related]
39. Mutations in Epigenetic Regulation Genes Are a Major Cause of Overgrowth with Intellectual Disability.
Tatton-Brown K; Loveday C; Yost S; Clarke M; Ramsay E; Zachariou A; Elliott A; Wylie H; Ardissone A; Rittinger O; Stewart F; Temple IK; Cole T; ; Mahamdallie S; Seal S; Ruark E; Rahman N
Am J Hum Genet; 2017 May; 100(5):725-736. PubMed ID: 28475857
[TBL] [Abstract][Full Text] [Related]
40. Expanding the clinical and metabolic phenotype of DPM2 deficient congenital disorders of glycosylation.
Radenkovic S; Fitzpatrick-Schmidt T; Byeon SK; Madugundu AK; Saraswat M; Lichty A; Wong SYW; McGee S; Kubiak K; Ligezka A; Ranatunga W; Zhang Y; Wood T; Friez MJ; Clarkson K; Pandey A; Jones JR; Morava E
Mol Genet Metab; 2021 Jan; 132(1):27-37. PubMed ID: 33129689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
